RxDoctor Payments Data

Rustico Ramos, MD

Family Medicine · Farmington, MONPI 1730166505

Payments from drug & device makers

$806in general payments, 2019–2025

Across 48 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$257
  • AbbVie$134
  • Medtronic$129
  • Sunovion Pharmaceuticals Inc.$50
  • Amgen$37
  • Boehringer Ingelheim$37
  • plus $161 from 9 others

What the payments were for

  • Food & beverage$806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$806 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$3,040
Medicare patients
107
Services billed
190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide155$190,691
JardianceEmpagliflozin176$174,857
MounjaroTirzepatide90$107,020
EliquisApixaban85$70,461
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$61,336
OzempicSemaglutide36$35,925
Soliqua 100-33Insulin Glargine/Lixisenatide23$22,016
Spiriva HandihalerTiotropium Bromide34$20,471
XareltoRivaroxaban32$19,508
InvokanaCanagliflozin14$19,478
FarxigaDapagliflozin Propanediol28$17,302
Breo ElliptaFluticasone/Vilanterol32$13,947
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$12,022
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog28$12,004
RybelsusSemaglutide13$11,394

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$26$297,711245 claims
Boehringer IngelheimJardiance$37$174,857176 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arexvy$13$91,188128 claims
PfizerEliquis, Premarin, Abrysvo$257$78,464113 claims
Johnson & JohnsonXarelto, Invokana$15$38,98646 claims
AbbVieCreon$134$8,29238 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Farmington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →